← Human Trials & Peer-Reviewed Studies

Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: Vitamin D3 megadose reduces inflammatory markers.

Plain-language guide to PMID 25827670 (2015): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 40 women.

Key Facts

PMID
25827670
Journal
Experimental gerontology
Year
2015
Study type
Randomized Controlled Trial
Authors
de Medeiros Cavalcante IG et al. (8 authors)
DOI
10.1016/j.exger.2015.03.011

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

This study aimed to evaluate the effect of vitamin D3 megadose supplementation and influence of BsmI polymorphism in the VDR gene on the inflammatory profile and oxidative stress in elderly women with vitamin D deficiency.

Who Took Part

The abstract describes 40 women taking part.

PubMed indexes the participants as middle-aged adults and older adults, women only.

A double blind, randomized, placebo-controlled trial was conducted with 40 elderly women (aged 68±6 years) diagnosed with vitamin D insufficiency (24.7±3.1 ng/mL).

How the Study Was Run

In design terms this was a randomized, double-blind and placebo-controlled study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Neither the women nor the staff measuring them knew who was on Vitamin D, K2, Magnesium and Zinc, so expectations could not easily colour the readings.

Some women received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.

Blood samples were collected at baseline and after intervention to analyse the 25(OH)D, parathyroid hormone, serum calcium, ultra-sensitive C-reactive protein (them-CRP), alpha 1-acid glycoprotein (AGP-A), total antioxidant capacity (TAC), and malondialdehyde (MDA) levels, as well as the renal and hepatic function, and genotyping was performed for BsmI polymorphism.

What Was Measured

The subject headings attached to it are Biomarkers, C-Reactive Protein, Calcium, Cholecalciferol, Dietary Supplements, Genotype and Inflammation.

Author keywords: BsmI polymorphism, Elderly, Inflammation and oxidative stress, Supplementation and Vitamin D3.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 40 women.

The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2015 (Experimental gerontology), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.